Hepatitis in disseminated bacillus Calmette-Guerin infection

Canadian Journal of Gastroenterology

Volumn 14, Issue 4, 2000, Pages 333-336

  Göttke, Markus U ^a   Wong, Philip ^a   Muhn, Channy ^a   Jabbari, Mansour ^a   Morin, Suzanne ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Bacillus Calmette Guerin; Granulomatous hepatitis; Immunotherapy; Infection; Mycobacterium bovis; Syndrome of inappropriate antidiuretic hormone secretion

Indexed keywords

BCG VACCINE; CORTICOSTEROID; TUBERCULOSTATIC AGENT;

AGED; ANOREXIA; ARTICLE; BACTERIAL INFECTION; BLADDER CARCINOMA; BLADDER CATHETERIZATION; BLADDER SURGERY; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; FEVER; HEPATITIS; HEPATOSPLENOMEGALY; HUMAN; JAUNDICE; LETHARGY; LIVER BIOPSY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0034107864     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/409570     Document Type: Article

References (19)

1. Mathé G, Amiel J, Schwartzenberg L, et al Active immunotherapy for acute lymphoblastic leukemia. Lancet 1969;i:697-9.
2. Morales A, Nickel JC. Immunotherapy for superficial bladder cancer. A developmental and clinical overview. Urol Clin North Am 1992;19:549-56.
3. Barza MJ, Blum JH, Graeme-Cook FM. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmerre-Guérin for bladder cancer. N Engl J Med 1998;339:831-7.
4. Zbar B, Bernstein ID, Bartlett GL, Hanna MJ Jr, Rapp HJ. Immunotherapy of cancer: regression of intradermal tumors and presentation of growth of lymph node metastases after intralesional injection of living Mycobocterium bovis. J Natl Cancer Inst 1972;49:119-30.
5. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976;116:180.
6. Rosenberg SA, Seipp C, Sears HF. Clinical and immunologic studies of disseminated BCG infection. Cancer 1978;41:1771-80.
7. Flippin T, Mukherji B, Dayal Y. Granulomatous hepatitis as a late complication of BCG immunotherapy. Cancer 1980;46:1759-62.
8. Marans HY, Bekirov HM. Granulomatous hepatitis following intravesical bacillus Calmette-Guérin therapy for bladder carcinoma. J Urol 1987;137:111-2.
9. Thompson D, Cumming J. Granulomatous hepatitis following intravesical BCG therapy. Br J Urol 1990;66:432-3.
10. Graziano DA, Jacobs D, Lozano RG, Buck RL. A case of granulomatous hepatitis after mtravesical bacillus Calmette Guérin administration. J Urol 1991;146:1118-9.
11. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
12. Molina JM, Rabian C, D'Agay MF, Modai J. Hypersensitivity systemic reaction following intravesical bacillus Calmette Guérin, successful treatment with steroids. J Urol 1992;147:695-7.
13. Proctor DD, Chopra S, Rubenstein SC, Jokela JA, Uhl L. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guérin instillation for bladder carcinoma. Am J Gastroenterol 1993;88:1112-5.
14. Lyons D, Miller I, Jeffers A. Systemic hypersensitivity reaction to intravesical BCG. Scott Med J 1994;39:49-50.
15. Arzt MR, Forouhar F. Granulomatous hepatitis as a complication of intravesical bacillus Calmette Guérin therapy for bladder carcinoma Ann Clin Lab Sci 1995;25:409-13.
16. Leebeek FWG, Ouwendijk RJT, Kolk AHJ, et al. Granulomatous hepatitis caused by bacillus Calmette-Guérin (BCG) infection after BCG bladder instillation Gut 1996;38:616-8.
17. Sosnowski JT. Complications of bacillus Calmette-Guérin (BCG) immunotherapy in superficial bladder cancer. Compr Ther 1994;20:695-701.
18. Brosman SA. Bacillus Calmette-Guérin immunotherapy. Techniques and results. Urol Clin North Am 1992;19:557-64.
19. Lamm DL. Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 1992;19:565-72.